Mestrualia secures CE mark for Sobek diagnostic platformItalian startup Mestrualia secured CE mark approval for Sobek, its noninvasive diagnostic platform that combines blood and saliva biomarkers analysis to investigate biological signals that may be connected with early physiological changes linked to chronic disease. The company said it wants to change how women’s health conditions are diagnosed and is preparing clinical pilot programs of the device to assess how the test performs in real-world settings and whether it can support earlier identification and monitoring of chronic conditions.